Form D · Other

CordovaCann Corp.

Toronto, A6 · CIK 0001168981

Offering snapshot reported Apr 21, 2022 · SEC filing

Reported sold
$1.67M
Offering amount: $3.34M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 20, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 21, 2022Initial$1,671,500No comparison7SEC filing
Aug 31, 2021Initial$523,799No comparisonNot reportedSEC filing
Apr 1, 2021Initial$1,064,205No comparison3SEC filing
Mar 16, 2021Initial$1,424,607No comparison28SEC filing
Sep 2, 2020Initial$501,785No comparison15SEC filing
Jun 15, 2020Initial$826,091No comparison22SEC filing
Jun 15, 2020Initial$1,053,481No comparison30SEC filing
Aug 29, 2019Initial$535,677No comparison14SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-442898
Total Remaining to be Sold is the aggregate purchase price of shares underlying warrants sold in this offering. U.S. dollar amounts are based on the Bank of Canada exchange rate 0.7999 reported on April 20, 2022.
Each Unit is comprised of 1 common share in the capital of the Corporation and 1 warrant of the Corporation; each Warrant entitles the holder to purchase 1 Common Share of the Corporation for US$1.00 per share for 24 months following the date of issuance.

Source: Form D, filed Apr 21, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Benjamin T. Higham Director
Ashish Kapoor Executive
Henry Kloepper Director
Eric Lowy Director
Nathan Nienhuis Director, Executive
Dale Rasmussen Director
Jakob Ripshtein Director
Benjamin T. Highham Director
Thomas Jr. Turner Director, Executive
Thomas Turner Jr Director, Executive
Thomas Turner Jr. Director, Executive
Thomas Turner, Jr. Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
217 Queen Street West Suite 401
Toronto, A6, M5V 0R2